Literature DB >> 35061948

Design of Experiment Approach to Modeling the Effects of Formulation and Drug Loading on the Structure and Properties of Therapeutic Nanogels.

Hei Ming Kenneth Ho1,2, Duncan Q M Craig1, Richard M Day2.   

Abstract

The physical properties of nanoparticles may affect the uptake mechanism, biodistribution, stability, and other physicochemical properties of drug delivery systems. This study aimed to first develop a model exploring the factors controlling the nanogel physical properties using a single drug (propranolol), followed by an evaluation of whether these models can be applied more generally to a range of drugs. Size, polydispersity, ζ potential, and encapsulation efficiency were investigated using a design of experiment (DOE) approach to optimize formulations by systematically identifying the effects of, and interactions between, parameters associated with nanogel formulation and drug loading. Three formulation factors were selected, namely, chitosan concentration, the ratio between the chitosan and cross-linker─sodium triphosphate─and the ratio between the chitosan and drug. The results indicate that the DOE approach can be used not only to model but also to predict the size and polydispersity index (PDI). To explore the application of these prediction models with other drugs and to identify the relationship between the drug structure and nanogel properties, nanogels loaded with 12 structurally distinct drugs and 6 structurally similar drugs were fabricated at the optimal condition for propranolol in the model. The measured size, PDI, and ζ potential of the nanogels could not be modeled using distinct DOE parameters for dissimilar drugs, indicating that each drug requires a separate analysis. Nevertheless, for drugs with structural similarities, various linear and nonlinear trends were observed in the size, PDI, and ζ potential of nanogels against selected molecular descriptors, indicating that there are indeed relationships between the drug molecular structure and the performance outcomes, which may be modeled and predicted using the DOE approach. In conclusion, the study demonstrates that DOE models can be applied to model and predict the influence of formulation and drug loading on key performance parameters. While distinct models are required for structurally unrelated drugs, it was possible to establish correlations for the drug series investigated, which were based on polarity, hydrophobicity, and polarizability, thereby elucidating the importance of the interactions between the drug and the nanogels based on the nanogel properties and thus deepening the understanding of the drug-loading mechanisms in nanogels.

Entities:  

Keywords:  chitosan; design of experiment; nanogels; prediction; tunable

Mesh:

Substances:

Year:  2022        PMID: 35061948      PMCID: PMC9097514          DOI: 10.1021/acs.molpharmaceut.1c00699

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   5.364


  16 in total

1.  Uptake of chitosan and associated insulin in Caco-2 cell monolayers: a comparison between chitosan molecules and chitosan nanoparticles.

Authors:  Zengshuan Ma; Lee-Yong Lim
Journal:  Pharm Res       Date:  2003-11       Impact factor: 4.200

Review 2.  Bio-inspired adhesive catechol-conjugated chitosan for biomedical applications: A mini review.

Authors:  Ji Hyun Ryu; Seonki Hong; Haeshin Lee
Journal:  Acta Biomater       Date:  2015-08-28       Impact factor: 8.947

3.  Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.

Authors:  Quan Gan; Tao Wang
Journal:  Colloids Surf B Biointerfaces       Date:  2007-04-24       Impact factor: 5.268

4.  Tartrate/tripolyphosphate as co-crosslinker for water soluble chitosan used in protein antigens encapsulation.

Authors:  Gopal Srivastava; Shilratna Walke; Dilip Dhavale; Wasudeo Gade; Jignesh Doshi; Rakesh Kumar; Satish Ravetkar; Pooja Doshi
Journal:  Int J Biol Macromol       Date:  2016-05-28       Impact factor: 6.953

5.  Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel.

Authors:  Raida Al-Kassas; Jingyuan Wen; Angel En-Miao Cheng; Amy Moon-Jung Kim; Stephanie Sze Mei Liu; Joohee Yu
Journal:  Carbohydr Polym       Date:  2016-06-25       Impact factor: 9.381

6.  Preparation of optimized lipid-coated calcium phosphate nanoparticles for enhanced in vitro gene delivery to breast cancer cells.

Authors:  Jie Tang; Li Li; Christopher B Howard; Stephen M Mahler; Leaf Huang; Zhi Ping Xu
Journal:  J Mater Chem B       Date:  2015-07-29       Impact factor: 6.331

7.  Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study.

Authors:  Hosniyeh Hosseinzadeh; Fatemeh Atyabi; Rassoul Dinarvand; Seyed Naser Ostad
Journal:  Int J Nanomedicine       Date:  2012-04-11

8.  Does the use of chitosan contribute to oxalate kidney stone formation?

Authors:  Moacir Fernandes Queiroz; Karoline Rachel Teodosio Melo; Diego Araujo Sabry; Guilherme Lanzi Sassaki; Hugo Alexandre Oliveira Rocha
Journal:  Mar Drugs       Date:  2014-12-29       Impact factor: 5.118

9.  The Chemistry Development Kit (CDK): an open-source Java library for Chemo- and Bioinformatics.

Authors:  Christoph Steinbeck; Yongquan Han; Stefan Kuhn; Oliver Horlacher; Edgar Luttmann; Egon Willighagen
Journal:  J Chem Inf Comput Sci       Date:  2003 Mar-Apr

10.  Synthesis, Characterization and Cytotoxic Evaluation of Graphene Oxide Nanosheets: In Vitro Liver Cancer Model

Authors:  Samah A Loutfy; Taher A Salaheldin; Marwa A Ramadan; Khaled Yehia Farroh; Zeinab F Abdallah; Tareq Youssef
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01
View more
  1 in total

1.  Fabrication of nanostructured lipid carriers ocugel for enhancing Loratadine used in treatment of COVID-19 related symptoms: statistical optimization, in-vitro, ex-vivo, and in-vivo studies evaluation.

Authors:  Rehab Abdelmonem; Inas Essam Ibrahim Al-Samadi; Rasha M El Nashar; Bhaskara R Jasti; Mohamed A El-Nabarawi
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.